BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27220318)

  • 1. Evaluation of
    Zhao M; Yang W; Zhang M; Li G; Wang S; Wang Z; Ma X; Kang F; Wang J
    Tumour Biol; 2016 Sep; 37(9):12123-12131. PubMed ID: 27220318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an Integrin α
    Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
    Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NGR-peptide-drug conjugates with dual targeting properties.
    Enyedi KN; Tóth S; Szakács G; Mező G
    PLoS One; 2017; 12(6):e0178632. PubMed ID: 28575020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multibarrier-penetrating drug delivery systems for deep tumor therapy based on synergistic penetration strategy.
    Zhang HF; Yu H; Pan SX; Zhang C; Ma YH; Zhang YF; Zuo LL; Hao CY; Lin XY; Geng H; Wu D; Mu SQ; Yu WL; Shi NQ
    Biomater Sci; 2024 Apr; 12(9):2321-2330. PubMed ID: 38488841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of probes for radiotheranostics with albumin binding moiety to increase the therapeutic effects of astatine-211 (
    Echigo H; Mishiro K; Munekane M; Fuchigami T; Washiyama K; Takahashi K; Kitamura Y; Wakabayashi H; Kinuya S; Ogawa K
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):412-421. PubMed ID: 37819452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray-Based CD38 Peptide Probe Screening for Multiple Myeloma Imaging.
    Li X; Wang Y; Yang Q; Song L; Kang L; Hu Z; Wang Z
    Mol Pharm; 2024 Jan; 21(1):245-254. PubMed ID: 38096423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-triggered nanoaggregation probe.
    Shen B; Jeon J; Palner M; Ye D; Shuhendler A; Chin FT; Rao J
    Angew Chem Int Ed Engl; 2013 Sep; 52(40):10511-4. PubMed ID: 23881906
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wang Y; Sun Y; Zeng X; Zhuang R; Huang J; Zhang X; Guo Z; Li Y
    J Med Chem; 2024 Feb; 67(3):2165-2175. PubMed ID: 38270637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines.
    Kunjachan S; Pola R; Gremse F; Theek B; Ehling J; Moeckel D; Hermanns-Sachweh B; Pechar M; Ulbrich K; Hennink WE; Storm G; Lederle W; Kiessling F; Lammers T
    Nano Lett; 2014 Feb; 14(2):972-81. PubMed ID: 24422585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Imaging of Acute Hindlimb Ischaemia in Rat Model: A Pre-Clinical PET Study.
    Farkasinszky G; Péliné JS; Károlyi P; Rácz S; Dénes N; Papp T; Király J; Szabo Z; Kertész I; Mező G; Halmos G; Képes Z; Trencsényi G
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma.
    Kessler T; Baumeier A; Brand C; Grau M; Angenendt L; Harrach S; Stalmann U; Schmidt LH; Gosheger G; Hardes J; Andreou D; Dreischalück J; Lenz G; Wardelmann E; Mesters RM; Schwöppe C; Berdel WE; Hartmann W; Schliemann C
    Transl Oncol; 2018 Dec; 11(6):1271-1282. PubMed ID: 30125801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropilin-1highCD4⁺CD25⁺ Regulatory T Cells Exhibit Primary Negative Immunoregulation in Sepsis.
    Gao YL; Chai YF; Qi AL; Yao Y; Liu YC; Dong N; Wang LJ; Yao YM
    Mediators Inflamm; 2016; 2016():7132158. PubMed ID: 27239104
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Chen X; Sun Y; Li F; Xi L; Dai J; Zhao C; Dong Q
    Am J Nucl Med Mol Imaging; 2024; 14(2):110-121. PubMed ID: 38737640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: A Preclinical Review.
    Trencsényi G; Enyedi KN; Mező G; Halmos G; Képes Z
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Performance Evaluation of
    Képes Z; Arató V; Szabó JP; Gyuricza B; Szücs D; Hajdu I; Fekete A; Bruchertseifer F; Szikra D; Trencsényi G
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy.
    Masłowska K; Halik PK; Tymecka D; Misicka A; Gniazdowska E
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of
    Yang Y; Zhang J; Zou H; Shen Y; Deng S; Wu Y
    J Cancer; 2021; 12(1):244-252. PubMed ID: 33391421
    [No Abstract]   [Full Text] [Related]  

  • 18. Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy.
    Zhu L; Ding Z; Li X; Wei H; Chen Y
    Mol Imaging; 2020; 19():1536012120934957. PubMed ID: 32862776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Penetrating Peptides, Novel Vectors for Gene Therapy.
    Taylor RE; Zahid M
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32138146
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.